| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 06/19/2002 | EP1214052A1 Veterinary formulation for administration of a water-insoluble drug to a target animal through a water distribution system |
| 06/19/2002 | EP1214039A2 Methods and compositions for preventing and treating urinary tract disorders |
| 06/19/2002 | EP1214038A2 Methods and compositions for preventing and treating prostate disorders |
| 06/19/2002 | EP1213974A1 Directly compressable raw material for tablets |
| 06/19/2002 | EP1213964A1 Phytochemicals for treatment of mastalgia and endometriosis |
| 06/19/2002 | EP1067903B1 Improved crystal structure |
| 06/19/2002 | EP1014943B1 Medical aerosol formulations |
| 06/19/2002 | EP0946149B1 Homogeneous preformulations containing high concentrations of steroids, for producing low-dose solid and semi-solid pharmaceutical preparations |
| 06/19/2002 | EP0906101B1 Slow-release pharmaceutical formulations containing mizolastin |
| 06/19/2002 | EP0879062B1 Nucleic acid delivery vehicle |
| 06/19/2002 | EP0866691B1 Sublingual and buccal administration of selegiline |
| 06/19/2002 | EP0754061B1 New oral pharmaceutical dosage form |
| 06/19/2002 | CN1354754A Injectable anthelmintic formulation |
| 06/19/2002 | CN1354678A Polyethyleneimine: DNA formulations for aerosol delivery |
| 06/19/2002 | CN1354677A Topical compositions for prostaglandin E1 delivery |
| 06/19/2002 | CN1354675A Adjuvant combination formulations |
| 06/19/2002 | CN1354669A Pharmaceutical compositions of erythropoietin |
| 06/19/2002 | CN1354667A Use of camptotheicin derivatives with reduced gastrointestinal toxicity |
| 06/19/2002 | CN1354665A Sustained release ranolazine formulations |
| 06/19/2002 | CN1354664A Injectable naltrexone microsphere compositions and their use in reducing consumption of heroinb and alcohol |
| 06/19/2002 | CN1354663A Sulfonamide and sulfamide substituted imidazoquinolines |
| 06/19/2002 | CN1354660A Orally administrable pharmaceutical preparation having therapeutic effect on gastrointestinal disorders comprising coated ranitidine, bismuth subcitrate and sucralfate |
| 06/19/2002 | CN1354657A EGF-R antagonists for treating hypersecretion of mucus in lungs |
| 06/19/2002 | CN1354656A Compositions and methods for mucosal delivery |
| 06/19/2002 | CN1354655A Pharmaceutical preparations for external use containing non-steroidal anti-inflammatory and analgesic agents |
| 06/19/2002 | CN1354654A Transdermal therapeutic system with neutralized pressure sensitiivty acrylic adhesive patch |
| 06/19/2002 | CN1354653A Compressed compositions comprising clarified xanthan gum |
| 06/19/2002 | CN1354652A Milling process for production of finely milled medicinal substances |
| 06/19/2002 | CN1354640A Composition and formulations and their use as nociceptic, anti-anxiolytic and anabolic agents |
| 06/19/2002 | CN1354624A Controlling release of active agents from chewing gum coating |
| 06/19/2002 | CN1354015A Health-care product containing growth factor and its preparation method |
| 06/19/2002 | CN1354014A Gongbu ointment |
| 06/19/2002 | CN1353997A Chinese herbal medicine foot effervescent tablets |
| 06/19/2002 | CN1353992A Notoginsenoside enteric tablet |
| 06/19/2002 | CN1353991A Ginsenoside enteric tablet |
| 06/19/2002 | CN1353990A Preparation for analgesia and anesthesia or curing drug dependence |
| 06/19/2002 | CN1353985A Matter or composition for treatment of cancer |
| 06/19/2002 | CN1353984A Far infrared nano plaster |
| 06/19/2002 | CN1353983A Enteric tablet coating liquor and its preparation method |
| 06/19/2002 | CN1353982A Nano Chinese medicine powder |
| 06/19/2002 | CN1353981A Quick-acting aerosol for resisting angina cordis and its preparation method |
| 06/19/2002 | CN1353980A Quick-acting aerosol for relieving asthma and its preparation method |
| 06/19/2002 | CN1353972A Asiaticoside antisticking film and its preparation method |
| 06/19/2002 | CN1086296C Compound donkey-hide gelatin preparation for preventing arrest of bone marrow in chemotherapy and radiotherapy and preparing method thereof |
| 06/19/2002 | CN1086292C Scorption and ant medicinal liquor |
| 06/18/2002 | US6407278 Stable amorphous amifostine compositions and methods for the preparation and use of the same |
| 06/18/2002 | US6407239 Topoisomerase inhibitors |
| 06/18/2002 | US6407204 Use of conantokins for producing analgesia or for neuoprotection |
| 06/18/2002 | US6407178 Complexing |
| 06/18/2002 | US6407158 Neutralized pyrrolidone polymer containing itaconic acid and diamine monomers; cosmetics, shampoo |
| 06/18/2002 | US6407125 Administering 2-carboxypyridine derivative to treat skin, respiratory system, and immune disorders; anticarcinogenic, antiinflammatory and antiviral agents; deactivating metal-protein complexes |
| 06/18/2002 | US6407117 Administering irinotecan hydrochloride and bicarbonate to maintain intestinal lumen alkalinity and prevent diarrhea; aids treatment |
| 06/18/2002 | US6407079 Inclusion compound etherified cyclodextrin; nontoxic, stability |
| 06/18/2002 | US6407078 AZT derivatives exhibiting spermicidal and anti-viral activity |
| 06/18/2002 | US6407070 Mixture containing granulation agent; therapy for kidney disease |
| 06/18/2002 | US6407061 Absorption through nasal mucous membrane |
| 06/18/2002 | US6407057 Ovulation triggering drugs |
| 06/18/2002 | US6406839 Methods for using a plasma-like solution |
| 06/18/2002 | US6406745 Methods for coating particles and particles produced thereby |
| 06/18/2002 | US6406738 Powder coating composition for electrostatic coating of pharmaceutical substrates |
| 06/18/2002 | US6406719 Encapsulation of bioactive agents |
| 06/18/2002 | US6406717 Rapid-melt semi-solid compositions, methods of making same and methods of using same |
| 06/18/2002 | US6406716 Comprising neuropathic pain-alleviating amount of anticonvulsant and anticonvulsant-potentiating amount of antagonist for n-methyl-d-aspartate receptor or substance that blocks major intracellular consequence of receptor activation |
| 06/18/2002 | US6406715 Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique urinary metabolite profiles |
| 06/18/2002 | US6406714 Dry mix formulation for bisphosphonic acids |
| 06/18/2002 | US6406713 Dissolving lipids in solvent, polyene antifungal agent such as amphotericin b and complexing by mixing; fda orange book listed patent |
| 06/18/2002 | US6406706 Use of α- and β-santalols major constituents of sandal wood oil, in the treatment of warts, skin blemishes and other viral-induced tumors |
| 06/18/2002 | US6406703 Treatment of H. pylori associated gastroduodenal disease |
| 06/18/2002 | US6406699 Composition and method of cancer antigen immunotherapy |
| 06/18/2002 | US6406692 Infections for eyes treated with eye drops |
| 06/18/2002 | US6406681 Propellents and drugs |
| 06/18/2002 | CA2249375C Propofol microdroplet formulations |
| 06/13/2002 | WO2002046241A2 Polynuclear complex fe(iii) with pullulan oligomers, process of its obtaining, and pharmaceutical preparations on the basis of the complex |
| 06/13/2002 | WO2002046240A1 Multicomponent compositions containing chitosan and methods of preparing same |
| 06/13/2002 | WO2002046239A1 Thermoplastic and water soluble cellulose ether esters |
| 06/13/2002 | WO2002045779A2 Patient activated administration of drug bolus from implantable drug delivery system having timer for lockout interval |
| 06/13/2002 | WO2002045773A2 Use of electrolytes (ions in solution) to suppress charging of inhalation aerosols |
| 06/13/2002 | WO2002045769A2 A bilayer structure which encapsulates multiple containment units and uses thereof |
| 06/13/2002 | WO2002045754A2 Pharmaceutical compositions for the oral delivery of pharmacologically active agents |
| 06/13/2002 | WO2002045753A2 Oral extended release formulation of gepirone |
| 06/13/2002 | WO2002045752A2 Dermal anti-inflammatory composition |
| 06/13/2002 | WO2002045748A1 Ocular tension-lowering compositions for topical administration |
| 06/13/2002 | WO2002045746A2 Pharmaceutical compositions enhancing the immunogenicity of poorly immunogenic antigens |
| 06/13/2002 | WO2002045734A1 Tahitian noni juice on cox-1 and cox-2 and tahitian noni juice as a selective cox-2 inhibitor |
| 06/13/2002 | WO2002045733A2 Oral preprations having itching-relievign or antipruritic activity |
| 06/13/2002 | WO2002045730A1 Antimonocytic activity of extracts of piper betel leaves |
| 06/13/2002 | WO2002045721A1 Noble gas complexes |
| 06/13/2002 | WO2002045714A1 Drug formulation having improved oral tolerability |
| 06/13/2002 | WO2002045713A2 Orally-bioavailable formulations of fentanyl and congeners thereof |
| 06/13/2002 | WO2002045711A1 Use of anti-muscarinic agents and calcium channel blockers in combination |
| 06/13/2002 | WO2002045709A1 Clear propofol compositions |
| 06/13/2002 | WO2002045703A2 Mixtures or organic compounds for the treatmentof airway diseases |
| 06/13/2002 | WO2002045701A2 Crystallization inhibition of drugs in transdermal drug delivery systems |
| 06/13/2002 | WO2002045700A2 Absorbing agents and cover layer which is impermeable to active substances and which contains channel-formers or removable protective layer of a transdermal therapeutic system |
| 06/13/2002 | WO2002045699A2 Transdermal therapeutic system comprising the active ingredient oxybutynin |
| 06/13/2002 | WO2002045698A2 Silicone gel sheet for treatment of scar tissue |
| 06/13/2002 | WO2002045697A2 Composite material for counteracting edema |
| 06/13/2002 | WO2002045696A1 Drug delivery system |
| 06/13/2002 | WO2002045695A2 Hydrostatic delivery system for controlled delivery of agent |
| 06/13/2002 | WO2002045694A1 Rapidly disintegrating tablet comprising an acid-labile active ingredient |